NorthWest Biotherapeutics Inc (NWBO)

[dmb2]

I am not sure what to think about this data being used at this stage as NWBO cannot get ahead of themselves, though if the publication is out I think they have considerably more leeway to present their case. Since this data would not have been peer reviewed I think they would be cautious at this stage. Even if no publication by ASCO I think they will still need to divulge more than was divulged to date. All very interesting and the two leaders they have, Drs Liau and Ashkan, are tops, along with their respective organizations.